Ovarian cancer: how can resistance to chemotherapy be tackled?

被引：10

作者：

Karakashev, Sergey ^{[1
]}

Aird, Katherine M. ^{[2
]}

机构：

[1] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA

[2] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA

来源：

FUTURE ONCOLOGY | 2017年 / 13卷 / 30期

关键词：

BET inhibitors; chemoresistance; immunotherapy; ovarian cancer; BET BROMODOMAIN INHIBITION; T-CELLS; CHEMORESISTANCE;

D O I：

10.2217/fon-2017-0235

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：2737 / 2739

页数：3

共 20 条

[1] Ovarian cancer: Strategies for overcoming resistance to chemotherapy [J].

Agarwal, R ;

Kaye, SB .

NATURE REVIEWS CANCER, 2003, 3 (07) :502-516

[2] Cancer Epigenetics: From Mechanism to Therapy [J].

Dawson, Mark A. ;

Kouzarides, Tony .

CELL, 2012, 150 (01) :12-27

[3] Selective inhibition of BET bromodomains [J].

Filippakopoulos, Panagis ;

Qi, Jun ;

Picaud, Sarah ;

Shen, Yao ;

Smith, William B. ;

Fedorov, Oleg ;

Morse, Elizabeth M. ;

Keates, Tracey ;

Hickman, Tyler T. ;

Felletar, Ildiko ;

Philpott, Martin ;

Munro, Shonagh ;

McKeown, Michael R. ;

Wang, Yuchuan ;

Christie, Amanda L. ;

West, Nathan ;

Cameron, Michael J. ;

Schwartz, Brian ;

Heightman, Tom D. ;

La Thangue, Nicholas ;

French, Christopher A. ;

Wiest, Olaf ;

Kung, Andrew L. ;

Knapp, Stefan ;

Bradner, James E. .

NATURE, 2010, 468 (7327) :1067-1073

[4]

Gaillard Stephanie L, 2016, Gynecol Oncol Res Pract, V3, P11

[5] Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE1 and BRD4 genes in non-BRCAness high grade ovarian carcinoma [J].

Goundiam, Oumou ;

Gestraud, Pierre ;

Popova, Tatiana ;

Rouge, Thibault De la Motte ;

Fourchotte, Virginie ;

Gentien, David ;

Hupe, Philippe ;

Becette, Veronique ;

Houdayer, Claude ;

Roman-Roman, Sergio ;

Stern, Marc-Henri ;

Sastre-Garau, Xavier .

INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (08) :1890-1900

[6] Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer [J].

Huang, Ruea-Yea ;

Francois, Ariel ;

McGray, A. J. Robert ;

Miliotto, Anthony ;

Odunsi, Kunle .

ONCOIMMUNOLOGY, 2017, 6 (01)

[7] Cancer immunotherapy comes of age [J].

Mellman, Ira ;

Coukos, George ;

Dranoff, Glenn .

NATURE, 2011, 480 (7378) :480-489

[8] Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies [J].

Naidoo, J. ;

Page, D. B. ;

Li, B. T. ;

Connell, L. C. ;

Schindler, K. ;

Lacouture, M. E. ;

Postow, M. A. ;

Wolchok, J. D. .

ANNALS OF ONCOLOGY, 2015, 26 (12) :2375-2391

[9] The blockade of immune checkpoints in cancer immunotherapy [J].

Pardoll, Drew M. .

NATURE REVIEWS CANCER, 2012, 12 (04) :252-264

[10]

Pylväs-Eerola M, 2016, ANTICANCER RES, V36, P3425

← 1 2 →